Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells

Zhi-Kai Dai1, Jiang-Ke Qin, Jiao-E Huang

  • 1Department of Pharmacology, Pharmaceutical Institute of Guilin Medical University, 541004 Guilin, China.

Insights

Tanshinone IIA (Tan IIA) from Salvia miltiorrhiza induces cancer cell death by activating calcium-dependent pathways and upregulating MT 1A. This natural compound shows anticancer potential without harming stem cells.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Tanshinone IIA (Tan IIA), a natural product derived from Salvia miltiorrhiza Bunge, exhibits promising anti-tumor properties.
  • Understanding the precise molecular mechanisms of Tan IIA's action is crucial for its therapeutic development.

Purpose of the Study:

  • To elucidate the molecular pathways involved in Tan IIA-induced apoptosis in cancer cells.
  • To evaluate the safety profile of Tan IIA in human amniotic mesenchymal stem cells (HAMCs).

Main Methods:

  • Human hepatoma BEL-7402 cells were treated with Tan IIA and analyzed for viability (MTT assay), colony formation, apoptosis, and cell cycle progression (flow cytometry, fluorescence microscopy).
  • Intracellular calcium levels and mitochondrial membrane potential (∆ψ) were measured.
  • Gene expression of Bad and metallothionein 1A (MT 1A) was assessed using RT-PCR.

Main Results:

  • Tan IIA demonstrated dose- and time-dependent anticancer effects on BEL-7402 cells, inducing apoptosis and G(0)/G(1) cell cycle arrest.
  • Tan IIA treatment led to increased intracellular calcium, decreased mitochondrial membrane potential, and elevated Bad and MT 1A mRNA expression.
  • No cytotoxic effects were observed in HAMCs, indicating a favorable safety profile.

Conclusions:

  • Tan IIA-induced cancer cell apoptosis is mediated by the activation of calcium-dependent signaling pathways.
  • Upregulation of metallothionein 1A (MT 1A) expression is implicated in the anti-cancer mechanism of Tan IIA.
  • Tan IIA presents a potential therapeutic agent with selective toxicity towards cancer cells and safety in stem cells.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...